DEF 14A

Company

ANI PHARMACEUTICALS INC

Filed

April 5, 2024

Period of Report

December 31, 2023

Accession Number

0001023024-24-000037

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →